Characterization of circadian COPD symptoms by phenotype: Methodology of the STORICO observational study
Chronic obstructive pulmonary disease (COPD) is one of the leading causes of morbidity and mortality worldwide. The symptoms of COPD are troublesome, variable, can occur during all parts of the 24-h day and have a substantial impact on patients' health status, quality of life and healthcare res...
Uloženo v:
| Vydáno v: | European journal of internal medicine Ročník 43; s. 62 - 68 |
|---|---|
| Hlavní autoři: | , , , , , , , , |
| Médium: | Journal Article |
| Jazyk: | angličtina |
| Vydáno: |
Netherlands
Elsevier B.V
01.09.2017
|
| Témata: | |
| ISSN: | 0953-6205, 1879-0828, 1879-0828 |
| On-line přístup: | Získat plný text |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
| Abstract | Chronic obstructive pulmonary disease (COPD) is one of the leading causes of morbidity and mortality worldwide. The symptoms of COPD are troublesome, variable, can occur during all parts of the 24-h day and have a substantial impact on patients' health status, quality of life and healthcare resource utilization. Reducing symptoms, improving health status and increasing physical activity are major goals in the management of stable COPD. In order to provide effective, patient-oriented care, patients should be evaluated on the basis of lung function, frequency of symptoms and patient-perceived impact of symptoms on their lives and treatment decisions made on a case-by-case basis.
The identification of COPD phenotypes is an evolving debate and literature data about the circadian variation of COPD symptoms according to phenotypes are nowadays lacking. The ongoing STORICO (STudio Osservazionale sulla caratteRizzazione dei sIntomi delle 24 ore nei pazienti con BPCO) study (NCT03105999) is aimed to describe by clinically defined phenotypes the frequency and 12-month evolution of early-morning, day- and night-time COPD symptoms in a cohort of 600 Italian patients with stable COPD. Secondary objectives include the description of the 12-month variation of outcomes of interest according to phenotypes and of the healthcare resources utilization (overall and by phenotype) during 12-month observation. An exploratory analysis will be conducted aimed to phenotype COPD patients in an alternative researcher-independent way based on circadian pattern of symptoms combined with measures of respiratory function, health-related quality of life and comorbidity.
The present paper describes the methodology of the STORICO study.
•COPD symptoms are troublesome and can occur during all parts of the 24-h day.•COPD symptoms impact on patients' health status, QoL and healthcare resource use.•Data on COPD symptoms' circadian variation according to phenotypes are lacking.•STORICO study will describe the evolution of COPD symptoms by clinical phenotypes.•STORICO study will investigate COPD symptoms' circadian variations by phenotypes. |
|---|---|
| AbstractList | Chronic obstructive pulmonary disease (COPD) is one of the leading causes of morbidity and mortality worldwide. The symptoms of COPD are troublesome, variable, can occur during all parts of the 24-h day and have a substantial impact on patients' health status, quality of life and healthcare resource utilization. Reducing symptoms, improving health status and increasing physical activity are major goals in the management of stable COPD. In order to provide effective, patient-oriented care, patients should be evaluated on the basis of lung function, frequency of symptoms and patient-perceived impact of symptoms on their lives and treatment decisions made on a case-by-case basis.
The identification of COPD phenotypes is an evolving debate and literature data about the circadian variation of COPD symptoms according to phenotypes are nowadays lacking. The ongoing STORICO (STudio Osservazionale sulla caratteRizzazione dei sIntomi delle 24 ore nei pazienti con BPCO) study (NCT03105999) is aimed to describe by clinically defined phenotypes the frequency and 12-month evolution of early-morning, day- and night-time COPD symptoms in a cohort of 600 Italian patients with stable COPD. Secondary objectives include the description of the 12-month variation of outcomes of interest according to phenotypes and of the healthcare resources utilization (overall and by phenotype) during 12-month observation. An exploratory analysis will be conducted aimed to phenotype COPD patients in an alternative researcher-independent way based on circadian pattern of symptoms combined with measures of respiratory function, health-related quality of life and comorbidity.
The present paper describes the methodology of the STORICO study.
•COPD symptoms are troublesome and can occur during all parts of the 24-h day.•COPD symptoms impact on patients' health status, QoL and healthcare resource use.•Data on COPD symptoms' circadian variation according to phenotypes are lacking.•STORICO study will describe the evolution of COPD symptoms by clinical phenotypes.•STORICO study will investigate COPD symptoms' circadian variations by phenotypes. Chronic obstructive pulmonary disease (COPD) is one of the leading causes of morbidity and mortality worldwide. The symptoms of COPD are troublesome, variable, can occur during all parts of the 24-h day and have a substantial impact on patients' health status, quality of life and healthcare resource utilization. Reducing symptoms, improving health status and increasing physical activity are major goals in the management of stable COPD. In order to provide effective, patient-oriented care, patients should be evaluated on the basis of lung function, frequency of symptoms and patient-perceived impact of symptoms on their lives and treatment decisions made on a case-by-case basis. The identification of COPD phenotypes is an evolving debate and literature data about the circadian variation of COPD symptoms according to phenotypes are nowadays lacking. The ongoing STORICO (STudio Osservazionale sulla caratteRizzazione dei sIntomi delle 24 ore nei pazienti con BPCO) study (NCT03105999) is aimed to describe by clinically defined phenotypes the frequency and 12-month evolution of early-morning, day- and night-time COPD symptoms in a cohort of 600 Italian patients with stable COPD. Secondary objectives include the description of the 12-month variation of outcomes of interest according to phenotypes and of the healthcare resources utilization (overall and by phenotype) during 12-month observation. An exploratory analysis will be conducted aimed to phenotype COPD patients in an alternative researcher-independent way based on circadian pattern of symptoms combined with measures of respiratory function, health-related quality of life and comorbidity. The present paper describes the methodology of the STORICO study. Abstract Chronic obstructive pulmonary disease (COPD) is one of the leading causes of morbidity and mortality worldwide. The symptoms of COPD are troublesome, variable, can occur during all parts of the 24-h day and have a substantial impact on patients' health status, quality of life and healthcare resource utilization. Reducing symptoms, improving health status and increasing physical activity are major goals in the management of stable COPD. In order to provide effective, patient-oriented care, patients should be evaluated on the basis of lung function, frequency of symptoms and patient-perceived impact of symptoms on their lives and treatment decisions made on a case-by-case basis. The identification of COPD phenotypes is an evolving debate and literature data about the circadian variation of COPD symptoms according to phenotypes are nowadays lacking. The ongoing STORICO ( STudio Osservazionale sulla caratteRizzazione dei sIntomi delle 24 ore nei pazienti con BPCO ) study ( NCT03105999 ) is aimed to describe by clinically defined phenotypes the frequency and 12-month evolution of early-morning, day- and night-time COPD symptoms in a cohort of 600 Italian patients with stable COPD. Secondary objectives include the description of the 12-month variation of outcomes of interest according to phenotypes and of the healthcare resources utilization (overall and by phenotype) during 12-month observation. An exploratory analysis will be conducted aimed to phenotype COPD patients in an alternative researcher-independent way based on circadian pattern of symptoms combined with measures of respiratory function, health-related quality of life and comorbidity. The present paper describes the methodology of the STORICO study. Chronic obstructive pulmonary disease (COPD) is one of the leading causes of morbidity and mortality worldwide. The symptoms of COPD are troublesome, variable, can occur during all parts of the 24-h day and have a substantial impact on patients' health status, quality of life and healthcare resource utilization. Reducing symptoms, improving health status and increasing physical activity are major goals in the management of stable COPD. In order to provide effective, patient-oriented care, patients should be evaluated on the basis of lung function, frequency of symptoms and patient-perceived impact of symptoms on their lives and treatment decisions made on a case-by-case basis. The identification of COPD phenotypes is an evolving debate and literature data about the circadian variation of COPD symptoms according to phenotypes are nowadays lacking. The ongoing STORICO (STudio Osservazionale sulla caratteRizzazione dei sIntomi delle 24 ore nei pazienti con BPCO) study (NCT03105999) is aimed to describe by clinically defined phenotypes the frequency and 12-month evolution of early-morning, day- and night-time COPD symptoms in a cohort of 600 Italian patients with stable COPD. Secondary objectives include the description of the 12-month variation of outcomes of interest according to phenotypes and of the healthcare resources utilization (overall and by phenotype) during 12-month observation. An exploratory analysis will be conducted aimed to phenotype COPD patients in an alternative researcher-independent way based on circadian pattern of symptoms combined with measures of respiratory function, health-related quality of life and comorbidity. The present paper describes the methodology of the STORICO study.Chronic obstructive pulmonary disease (COPD) is one of the leading causes of morbidity and mortality worldwide. The symptoms of COPD are troublesome, variable, can occur during all parts of the 24-h day and have a substantial impact on patients' health status, quality of life and healthcare resource utilization. Reducing symptoms, improving health status and increasing physical activity are major goals in the management of stable COPD. In order to provide effective, patient-oriented care, patients should be evaluated on the basis of lung function, frequency of symptoms and patient-perceived impact of symptoms on their lives and treatment decisions made on a case-by-case basis. The identification of COPD phenotypes is an evolving debate and literature data about the circadian variation of COPD symptoms according to phenotypes are nowadays lacking. The ongoing STORICO (STudio Osservazionale sulla caratteRizzazione dei sIntomi delle 24 ore nei pazienti con BPCO) study (NCT03105999) is aimed to describe by clinically defined phenotypes the frequency and 12-month evolution of early-morning, day- and night-time COPD symptoms in a cohort of 600 Italian patients with stable COPD. Secondary objectives include the description of the 12-month variation of outcomes of interest according to phenotypes and of the healthcare resources utilization (overall and by phenotype) during 12-month observation. An exploratory analysis will be conducted aimed to phenotype COPD patients in an alternative researcher-independent way based on circadian pattern of symptoms combined with measures of respiratory function, health-related quality of life and comorbidity. The present paper describes the methodology of the STORICO study. |
| Author | Blasi, F. Zullo, A. Giovannetti, C. Canonica, G.W. Barsanti, S. Briguglio, C. Antonelli Incalzi, R. Scichilone, N. Simoni, L. |
| Author_xml | – sequence: 1 givenname: G.W. surname: Canonica fullname: Canonica, G.W. email: medidata@medineos.com organization: Personalized Medicine Asthma & Allergy Clinic, Humanitas University, Humanitas Research Hospital, Rozzano, Milan, Italy – sequence: 2 givenname: F. surname: Blasi fullname: Blasi, F. organization: Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Cardio-Thoracic Unit and Cystic Fibrosis Adult Center, Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico Milano, Milan, Italy – sequence: 3 givenname: N. surname: Scichilone fullname: Scichilone, N. organization: DIBIMIS University of Palermo, Palermo, Italy – sequence: 4 givenname: L. surname: Simoni fullname: Simoni, L. organization: Medineos Observational Research, Modena, Italy – sequence: 5 givenname: A. surname: Zullo fullname: Zullo, A. organization: Medineos Observational Research, Modena, Italy – sequence: 6 givenname: C. surname: Giovannetti fullname: Giovannetti, C. organization: Laboratori Guidotti, Pisa, Italy – sequence: 7 givenname: C. surname: Briguglio fullname: Briguglio, C. organization: Malesci, Firenze, Italy – sequence: 8 givenname: S. surname: Barsanti fullname: Barsanti, S. organization: Laboratori Guidotti, Pisa, Italy – sequence: 9 givenname: R. surname: Antonelli Incalzi fullname: Antonelli Incalzi, R. organization: University of Biomedical Campus of Rome, Rome, Italy |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/28576398$$D View this record in MEDLINE/PubMed |
| BookMark | eNqFkktv1TAQhS1URG8Lf4AF8pJNgu08XSEkFF6Vii6iZW05zoQ4JHGwnUrpr6_T224qUVazOd8ZzTlzgo4mMwFCrymJKaH5uz6GXo8xI7SISRYTRp-hHS0LHpGSlUdoR3iWRDkj2TE6ca4nQUhI8gIdszIr8oSXO9RVnbRSebD6RnptJmxarLRVstFywtX-xyfs1nH2ZnS4XvHcwWT8OsMZ_g6-M40ZzO91g3wH-PJq__O82mNTO7DXd35ywM4vzfoSPW_l4ODV_TxFv758vqq-RRf7r-fVx4tIpTnzUUMlpU1Sq7YlKi3zXBaNqtuCtmWWcQosbXhbq5IVUDMCOUsTLlXCs4LxvKZ5coreHnxna_4u4LwYtVMwDHICszhBOcmKlJCiDNI399KlHqERs9WjtKt4SCcIyoNAWeOchVYo7e-u8lbqQVAitiJEL7YixFaEIJkIRQSUPUIf3J-E3h8gCAFda7DCKQ2TgkZbUF40Rj-Nf3iEq0FPWsnhD6zgerPYUEeIQDgmiLjc3mP7DlokAedpMDj7t8H_tt8CPWzKbg |
| CitedBy_id | crossref_primary_10_1126_sciimmunol_aax1215 crossref_primary_10_1183_13993003_02094_2018 crossref_primary_10_1371_journal_pone_0221889 crossref_primary_10_2147_COPD_S240033 crossref_primary_10_1080_07420528_2019_1659291 crossref_primary_10_1007_s12325_022_02331_x crossref_primary_10_2147_COPD_S289697 crossref_primary_10_2147_COPD_S310428 crossref_primary_10_1186_s12890_019_0935_2 crossref_primary_10_1038_s41533_020_0163_5 |
| Cites_doi | 10.1378/chest.06-0702 10.1016/S0300-2896(09)72952-7 10.1016/j.psychres.2006.01.015 10.1136/thx.2006.067785 10.3109/15412555.2016.1150447 10.1136/thx.2008.108027 10.1164/rccm.201204-0596PP 10.1164/ajrccm/145.6.1321 10.1186/s12931-014-0122-1 10.1183/09031936.00051110 10.1016/S0140-6736(09)61303-9 10.1164/rccm.200912-1843CC 10.2147/COPD.S48570 10.1136/thx.54.7.581 10.1056/NEJMoa0909883 10.1183/09059180.00004311 10.1136/thx.2010.154484 10.1378/chest.08-2062 10.1016/j.arbres.2012.04.001 10.1185/03007990903103006 10.1378/chest.10-2948 10.1016/j.rmed.2006.07.010 10.2147/COPD.S2999 10.1097/00005768-200009001-00004 10.1111/j.1600-0447.1983.tb09716.x 10.1186/1477-7525-3-15 10.1016/0895-4356(94)90129-5 10.1016/j.arbres.2011.07.004 10.1016/0021-9681(87)90171-8 10.1016/S0954-6111(06)80166-6 10.1002/pon.1952 10.1016/j.arbres.2011.01.016 10.1164/ajrccm.153.5.8630597 10.1186/1477-7525-7-98 10.1016/j.arbres.2010.06.003 10.1186/1744-859X-7-4 10.1183/09031936.06.00124605 10.1186/1465-9921-14-112 10.1192/bjp.175.5.452 10.5578/tt.3268 10.3109/15412555.2013.844784 10.1016/S0022-3999(96)00216-4 10.1186/1477-7525-4-31 10.7326/0003-4819-127-12-199712150-00003 10.1081/COPD-200050513 10.1016/S0140-6736(07)61377-4 10.1183/09031936.00102509 |
| ContentType | Journal Article |
| Copyright | 2017 European Federation of Internal Medicine European Federation of Internal Medicine Copyright © 2017 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved. |
| Copyright_xml | – notice: 2017 European Federation of Internal Medicine – notice: European Federation of Internal Medicine – notice: Copyright © 2017 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved. |
| CorporateAuthor | STORICO study group |
| CorporateAuthor_xml | – name: STORICO study group |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 |
| DOI | 10.1016/j.ejim.2017.05.021 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1879-0828 |
| EndPage | 68 |
| ExternalDocumentID | 28576398 10_1016_j_ejim_2017_05_021 S0953620517302194 1_s2_0_S0953620517302194 |
| Genre | Multicenter Study Journal Article Observational Study |
| GroupedDBID | --- --K --M .1- .FO .GJ .~1 0R~ 1B1 1P~ 1~. 1~5 29G 4.4 457 4G. 53G 5GY 5VS 7-5 71M 8P~ AAEDT AAEDW AAIKJ AAKOC AALRI AAOAW AAQFI AATTM AAXKI AAXUO AAYWO ABBQC ABJNI ABLJU ABMAC ABMZM ABXDB ACDAQ ACIEU ACIUM ACLOT ACRLP ACVFH ADBBV ADCNI ADEZE AEBSH AEIPS AEKER AENEX AEUPX AEVXI AFJKZ AFPUW AFRHN AFTJW AFXIZ AGHFR AGUBO AGYEJ AIEXJ AIGII AIIUN AIKHN AITUG AJRQY AJUYK AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ ANKPU ANZVX APXCP ASPBG AVWKF AXJTR AZFZN BKOJK BLXMC BNPGV CS3 DU5 EBS EFJIC EFKBS EFLBG EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN G-Q GBLVA HVGLF HZ~ IHE J1W KOM M41 MO0 N9A O-L O9- OAUVE OD. OO~ OZT P-8 P-9 P2P PC. Q38 R2- ROL RPZ SCC SDF SDG SEL SES SEW SPCBC SSH SSZ T5K Z5R ~G- ~HD AACTN AFCTW AFKWA AJOXV AMFUW RIG 9DU AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 |
| ID | FETCH-LOGICAL-c462t-d1a11d3bcff0c4866a7dcbf71f85591e24d9fbc827eb20e62439ac3957296b163 |
| ISICitedReferencesCount | 9 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000414811400032&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 0953-6205 1879-0828 |
| IngestDate | Wed Oct 01 09:59:39 EDT 2025 Wed Feb 19 02:36:08 EST 2025 Sat Nov 29 02:42:44 EST 2025 Tue Nov 18 22:22:10 EST 2025 Wed Oct 15 12:53:19 EDT 2025 Sun Feb 23 10:18:46 EST 2025 Tue Oct 14 19:30:46 EDT 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Keywords | Phenotype Health-related quality of life (HRQoL) Healthcare resources utilization 24-Hour symptoms COPD |
| Language | English |
| License | Copyright © 2017 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved. |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-c462t-d1a11d3bcff0c4866a7dcbf71f85591e24d9fbc827eb20e62439ac3957296b163 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 ObjectType-Undefined-3 |
| PMID | 28576398 |
| PQID | 1905740078 |
| PQPubID | 23479 |
| PageCount | 7 |
| ParticipantIDs | proquest_miscellaneous_1905740078 pubmed_primary_28576398 crossref_citationtrail_10_1016_j_ejim_2017_05_021 crossref_primary_10_1016_j_ejim_2017_05_021 elsevier_sciencedirect_doi_10_1016_j_ejim_2017_05_021 elsevier_clinicalkeyesjournals_1_s2_0_S0953620517302194 elsevier_clinicalkey_doi_10_1016_j_ejim_2017_05_021 |
| PublicationCentury | 2000 |
| PublicationDate | 2017-09-01 |
| PublicationDateYYYYMMDD | 2017-09-01 |
| PublicationDate_xml | – month: 09 year: 2017 text: 2017-09-01 day: 01 |
| PublicationDecade | 2010 |
| PublicationPlace | Netherlands |
| PublicationPlace_xml | – name: Netherlands |
| PublicationTitle | European journal of internal medicine |
| PublicationTitleAlternate | Eur J Intern Med |
| PublicationYear | 2017 |
| Publisher | Elsevier B.V |
| Publisher_xml | – name: Elsevier B.V |
| References | Buist, McBurnie, Vollmer, Gillespie, Burney (bb0010) 2007; 370 Tantucci, Pini (bb0170) 2015; 10 Hurst, Vestbo, Anzueto, Locantore, Mullerova, Tal-Singer (bb0145) 2010; 363 White, Leach, Sims (bb0270) 1999; 175 Carrasco Garrido, de Miguel, Rejas Gutiérrez, Centeno, Gobartt Vázquez, Gil de Miguel (bb0095) 2006; 4 Espinosa de los Monteros, Pena, Soto Hurtado, Jareno, Miravitlles (bb0045) 2012; 48 Dixon, Massey (bb0280) 1983 Salvi, Barnes (bb0030) 2009; 374 Bestall, Paul, Garrod, Garnham, Jones, Wedzicha (bb0205) 1999; 54 Jones, Quirk, Baveystock (bb0225) 1991; 85 Jones, Harding, Berry, Wiklund, Chen, Kline (bb0210) 2009; 34 Tang, Wong, Chiu (bb0255) 2007; 150 Jones (bb0220) 2005; 2 Lange, Halpin, O'Donnell, MacNee (bb0175) 2016; 11 Wang, Hsu, Feng (bb0265) 2011; 20 Charlson, Szatrowski, Peterson, Gold (bb0190) 1994; 47 (bb0015) 2014 Singh, Miravitlles, Vogelmeier (bb0105) 15 December 2016 Agusti, Hedner, Marin, Barbe, Cazzola, Rennard (bb0070) 2011; 20 Charlson, Pompei, Ales, CR (bb0185) 1987; 40 (bb0110) 2017 Barth, Martin (bb0250) 2005; 3 Mannino (bb0020) 2006; 61 Meguro, Barley, Spencer, Jones (bb0235) 2006; 132 Halbert, Natoli, Gano, Badamgarav, Buist, Mannino (bb0005) 2006; 28 Roche, Chavannes, Miravitlles (bb0055) Oct 21 2013; 14 Miravitlles, Worth, Soler-Cataluña, Price, De Benedetto, Roche (bb0065) 2016; 13 Jones, Quirk, Baveystock, Littlejohns (bb0230) 1992; 145 Miravitlles, Worth, Soler Catalauña, Price, De Benedetto, Roche (bb0080) 2014; 15 Han, Agustí, Calverley (bb0140) 2010; 182 Miravitlles, Anzueto, Legnani, Forstmeier, Fargel (bb0090) 2007; 101 Kim, Han, Vance (bb0200) 2011; 140 Vestbo, Prescott, Lange (bb0165) 1996; 153 Santus, Radovanovic, Balzano, Pecchiari, Raccanelli, Sarno (bb0180) 2016; 92 Gibson, Simpson (bb0195) 2009; 64 Kessler, Partridge, Miravitlles, Cazzola, Vogelmeier, Leynaud (bb0035) 2011; 37 Ferrer, Alonso, Morera, Marrades, Khalaf, Aguar (bb0085) 1997; 127 Ainsworth, Bassett, Strath, Swartz, O'Brien, Thompson (bb0215) 2000; 32 Mannino, Doherty, Buist (bb0025) 2006; 100 Miravitlles (bb0130) 2009; 45 Vestbo, Hurd, Agustì, Jones, Vogelmeier, Anzueto (bb0100) 2013; 187 Zigmond, Snaith (bb0240) 1983; 67 Kuyucu, Güçlü, Şaylan, Demir, Şenol, Güner (bb0040) 2011; 59 Price, Small, Milligan, Higgins, Garcia Gil, Estruch (bb0075) 2013; 8 Michopoulos, Douzenis, Kalkavoura (bb0260) 2008; 7 Anderson, MacNee (bb0120) 2009; 4 Pokrzywinski, Meads, McKenna, Glendenning, Revicki (bb0275) 2009; 7 Miravitlles (bb0125) 2011; 47 Burgel, Nesme-Meyer, Chanez, Caillaud, Carre, Perez (bb0160) 2009; 135 Roche, Small, Broomfield, Higgins, Pollard (bb0060) 2013; 10 Garcia-Aymerich, Gómez, Benet, Farrero, Basagaña, Gayete (bb0150) 2011; 66 Lopez-Campos (bb0135) 2010; 46 Miravitlles, Soler-Cataluña, Calle, Molina, Almagro, Quintano (bb0155) Jul 2012; 48 Herrmann (bb0245) 1997; 42 Partridge, Karlsson, Small (bb0050) 2009; 25 (bb0115) 2016 Kuyucu (10.1016/j.ejim.2017.05.021_bb0040) 2011; 59 Gibson (10.1016/j.ejim.2017.05.021_bb0195) 2009; 64 Meguro (10.1016/j.ejim.2017.05.021_bb0235) 2006; 132 Buist (10.1016/j.ejim.2017.05.021_bb0010) 2007; 370 Mannino (10.1016/j.ejim.2017.05.021_bb0020) 2006; 61 Tantucci (10.1016/j.ejim.2017.05.021_bb0170) 2015; 10 Bestall (10.1016/j.ejim.2017.05.021_bb0205) 1999; 54 Agusti (10.1016/j.ejim.2017.05.021_bb0070) 2011; 20 Zigmond (10.1016/j.ejim.2017.05.021_bb0240) 1983; 67 Pokrzywinski (10.1016/j.ejim.2017.05.021_bb0275) 2009; 7 (10.1016/j.ejim.2017.05.021_bb0110) 2017 Ferrer (10.1016/j.ejim.2017.05.021_bb0085) 1997; 127 Miravitlles (10.1016/j.ejim.2017.05.021_bb0130) 2009; 45 Partridge (10.1016/j.ejim.2017.05.021_bb0050) 2009; 25 Kessler (10.1016/j.ejim.2017.05.021_bb0035) 2011; 37 Garcia-Aymerich (10.1016/j.ejim.2017.05.021_bb0150) 2011; 66 Singh (10.1016/j.ejim.2017.05.021_bb0105) 2016 Tang (10.1016/j.ejim.2017.05.021_bb0255) 2007; 150 Miravitlles (10.1016/j.ejim.2017.05.021_bb0080) 2014; 15 Charlson (10.1016/j.ejim.2017.05.021_bb0190) 1994; 47 Charlson (10.1016/j.ejim.2017.05.021_bb0185) 1987; 40 Jones (10.1016/j.ejim.2017.05.021_bb0210) 2009; 34 Vestbo (10.1016/j.ejim.2017.05.021_bb0100) 2013; 187 Roche (10.1016/j.ejim.2017.05.021_bb0060) 2013; 10 Miravitlles (10.1016/j.ejim.2017.05.021_bb0125) 2011; 47 Kim (10.1016/j.ejim.2017.05.021_bb0200) 2011; 140 Dixon (10.1016/j.ejim.2017.05.021_bb0280) 1983 Herrmann (10.1016/j.ejim.2017.05.021_bb0245) 1997; 42 Michopoulos (10.1016/j.ejim.2017.05.021_bb0260) 2008; 7 Ainsworth (10.1016/j.ejim.2017.05.021_bb0215) 2000; 32 Lopez-Campos (10.1016/j.ejim.2017.05.021_bb0135) 2010; 46 Han (10.1016/j.ejim.2017.05.021_bb0140) 2010; 182 Price (10.1016/j.ejim.2017.05.021_bb0075) 2013; 8 Vestbo (10.1016/j.ejim.2017.05.021_bb0165) 1996; 153 Burgel (10.1016/j.ejim.2017.05.021_bb0160) 2009; 135 Jones (10.1016/j.ejim.2017.05.021_bb0225) 1991; 85 Miravitlles (10.1016/j.ejim.2017.05.021_bb0065) 2016; 13 Salvi (10.1016/j.ejim.2017.05.021_bb0030) 2009; 374 Jones (10.1016/j.ejim.2017.05.021_bb0220) 2005; 2 Halbert (10.1016/j.ejim.2017.05.021_bb0005) 2006; 28 Espinosa de los Monteros (10.1016/j.ejim.2017.05.021_bb0045) 2012; 48 Roche (10.1016/j.ejim.2017.05.021_bb0055) 2013; 14 Santus (10.1016/j.ejim.2017.05.021_bb0180) 2016; 92 Anderson (10.1016/j.ejim.2017.05.021_bb0120) 2009; 4 Lange (10.1016/j.ejim.2017.05.021_bb0175) 2016; 11 Barth (10.1016/j.ejim.2017.05.021_bb0250) 2005; 3 Hurst (10.1016/j.ejim.2017.05.021_bb0145) 2010; 363 Mannino (10.1016/j.ejim.2017.05.021_bb0025) 2006; 100 Miravitlles (10.1016/j.ejim.2017.05.021_bb0090) 2007; 101 Jones (10.1016/j.ejim.2017.05.021_bb0230) 1992; 145 White (10.1016/j.ejim.2017.05.021_bb0270) 1999; 175 Carrasco Garrido (10.1016/j.ejim.2017.05.021_bb0095) 2006; 4 Wang (10.1016/j.ejim.2017.05.021_bb0265) 2011; 20 Miravitlles (10.1016/j.ejim.2017.05.021_bb0155) 2012; 48 |
| References_xml | – volume: 54 start-page: 581 year: 1999 end-page: 586 ident: bb0205 article-title: Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease publication-title: Thorax – volume: 48 start-page: 3 year: 2012 end-page: 7 ident: bb0045 article-title: Variability of respiratory symptoms in severe COPD publication-title: Arch Bronconeumol – volume: 8 start-page: 595 year: 2013 end-page: 603 ident: bb0075 article-title: Impact of night-time symptoms in COPD: a real-world study in five European countries publication-title: Int J Chron Obstruct Pulmon Dis – volume: 92 start-page: 295 year: 2016 end-page: 307 ident: bb0180 article-title: Improvements in Lung Diffusion Capacity Following Pulmonary Rehabilitation in COPD With and Without Ventilation Inhomogeneity Respiration – volume: 45 start-page: 27 year: 2009 end-page: 34 ident: bb0130 article-title: Tratamiento individualizado de la EPOC: una propuesta de cambio publication-title: Arch Bronconeumol – volume: 85 start-page: 25 year: 1991 end-page: 31 ident: bb0225 article-title: The St George's respiratory questionnaire publication-title: Respir Med – volume: 4 start-page: 321 year: 2009 end-page: 335 ident: bb0120 article-title: Targeted treatment in COPD: a multi-system approach for a multi-system disease publication-title: Int J Chron Obstruct Pulmon Dis – volume: 150 start-page: 97 year: 2007 end-page: 103 ident: bb0255 article-title: Rasch analysis of the scoring scheme of the HADS depression subscale in Chinese stroke patients publication-title: Psychiatry Res – volume: 59 start-page: 328 year: 2011 end-page: 339 ident: bb0040 article-title: A cross-sectional observational study to investigate daily symptom variability, effects of symptom on morning activities and therapeutic expectations of patients and physicians in COPD-SUNRISE study publication-title: Tüberküloz ve Toraks Dergisi – year: 2014 ident: bb0015 article-title: Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) – volume: 10 start-page: 1 year: 2013 end-page: 8 ident: bb0060 article-title: Real world COPD: association of morning symptoms with clinical and patient reported outcomes publication-title: COPD: J Chron Obstruct Pulmon Dis – volume: 132 start-page: 456 year: 2006 end-page: 463 ident: bb0235 article-title: Development and validation of an improved COPD-specific version of the St George's respiratory questionnaire publication-title: Chest – volume: 175 start-page: 452 year: 1999 end-page: 454 ident: bb0270 article-title: Validation of the HADS in adolescents publication-title: Br J Psychiatry – volume: 32 start-page: S457 year: 2000 end-page: S464 ident: bb0215 article-title: Comparison of three methods for measuring the time spent in physical activity publication-title: Med Sci Sports Exerc – volume: 4 start-page: 31 year: 2006 ident: bb0095 article-title: Negative impact of chronic obstructive pulmonary disease on the health-related quality of life of patients. Results of the EPIDEPOC study publication-title: Health Qual Life Outcomes – year: 2017 ident: bb0110 article-title: Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) – volume: 40 start-page: 373 year: 1987 end-page: 383 ident: bb0185 article-title: A new method of classifying prognostic comorbidity in longitudinal studies: development and validation publication-title: J Chronic Dis – volume: 42 start-page: 17 year: 1997 end-page: 41 ident: bb0245 article-title: International experiences with the hospital anxiety and depression scale—a review of validation data and clinical results publication-title: J Psychosom Res – volume: 37 start-page: 264 year: 2011 end-page: 272 ident: bb0035 article-title: Symptom variability in patients with severe COPD: a pan-European cross-sectional study publication-title: Eur Respir J – volume: 101 start-page: 453 year: 2007 end-page: 460 ident: bb0090 article-title: Patient's perception of exacerbations of COPD – the PERCEIVE study publication-title: Respir Med – volume: 20 start-page: 639 year: 2011 end-page: 646 ident: bb0265 article-title: The HADS and the DT for screening psychosocial distress of cancer patients in Taiwan publication-title: Psychooncology – volume: 13 start-page: 561 year: 2016 end-page: 568 ident: bb0065 article-title: The relationship between 24hour symptoms and COPD exacerbations and healthcare resource use: results from an observational study (ASSESS) publication-title: COPD: J Chron Obstruct Pulmon Dis – volume: 61 start-page: 1032 year: 2006 end-page: 1034 ident: bb0020 article-title: Underdiagnosed chronic obstructive pulmonary disease in England: new country, same story publication-title: Thorax – volume: 28 start-page: 523 year: 2006 end-page: 532 ident: bb0005 article-title: Global burden of COPD: systematic review and meta-analysis publication-title: Eur Respir J – volume: 187 start-page: 347 year: 2013 end-page: 365 ident: bb0100 article-title: Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary publication-title: Am J Respir Crit Care Med – volume: 7 start-page: 4 year: 2008 ident: bb0260 article-title: Hospital Anxiety and Depression Scale (HADS): validation in a Greek general hospital sample publication-title: Ann Gen Psychiatry – volume: 11 start-page: 3 year: 2016 end-page: 12 ident: bb0175 article-title: Diagnosis, assessment, and phenotyping of COPD: beyond FEV1 publication-title: Int J Chron Obstruct Pulmon Dis – volume: 25 start-page: 2043 year: 2009 end-page: 2048 ident: bb0050 article-title: Patient insight into the impact of chronic obstructive pulmonary disease in the morning: an internet survey publication-title: Curr Med Res Opin – volume: 370 start-page: 741 year: 2007 end-page: 750 ident: bb0010 article-title: International variation in the prevalence of COPD (The BOLD Study): a population-based prevalence study publication-title: Lancet – volume: 7 start-page: 98 year: 2009 ident: bb0275 article-title: Development and psychometric assessment of the COPD and Asthma Sleep Impact Scale (CASIS) publication-title: Health Qual Life Outcomes – volume: 20 start-page: 183 year: 2011 end-page: 194 ident: bb0070 article-title: Night-time symptoms: a forgotten dimension of COPD publication-title: Eur Respir Rev – year: 2016 ident: bb0115 article-title: Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) – volume: 47 start-page: 271 year: 2011 ident: bb0125 article-title: Corticosteroides inhalados en la EPOC por fenotipo en lugar de por gravedad. Argumentos a favor publication-title: Arch Bronconeumol – volume: 15 start-page: 122 year: 2014 ident: bb0080 article-title: Observational study to characterize 24-hour COPD symptoms and their relationship with patient-reported outcomes; results from the ASSESS study publication-title: Respir Res – volume: 135 start-page: 975 year: 2009 end-page: 982 ident: bb0160 article-title: Cough and sputum production are associated with frequent exacerbations and hospitalizations in COPD subjects publication-title: Chest – volume: 34 start-page: 648 year: 2009 end-page: 654 ident: bb0210 article-title: Development and first validation of the COPD Assessment Test publication-title: Eur Respir J – volume: 140 start-page: 626 year: 2011 end-page: 633 ident: bb0200 article-title: The chronic bronchtic phenotype of COPD. An analysis of the COPD gene study publication-title: Chest – volume: 153 start-page: 1530 year: 1996 end-page: 1535 ident: bb0165 article-title: Association of chronic mucus hypersecretion with FEV1 decline and chronic obstructive pulmonary disease morbidity. Copenhagen City Heart Study Group publication-title: Am J Respir Crit Care Med – volume: 67 start-page: 361 year: 1983 end-page: 370 ident: bb0240 article-title: The hospital anxiety and depression scale publication-title: Acta Psychiatr Scand – volume: 47 start-page: 1245 year: 1994 end-page: 1251 ident: bb0190 article-title: Validation of a combined comorbidity index publication-title: J Clin Epidemiol – volume: 66 start-page: 430 year: 2011 end-page: 437 ident: bb0150 article-title: Identification and prospective validation of clinically relevant chronic obstructive pulmonary disease (COPD) phenotypes publication-title: Thorax – year: 1983 ident: bb0280 article-title: Introduction to Statistical Analysis – volume: 10 start-page: 2451 year: 2015 end-page: 2457 ident: bb0170 article-title: COPD: it is time to change! publication-title: Int J COPD – volume: 363 start-page: 1128 year: 2010 end-page: 1138 ident: bb0145 article-title: Susceptibility to exacerbation in chronic obstructive pulmonary disease publication-title: N Engl J Med – volume: 127 start-page: 1072 year: 1997 end-page: 1079 ident: bb0085 article-title: Chronic obstructive pulmonary disease stage and health-related quality of life. The quality of life of chronic obstructive pulmonary disease study group publication-title: Ann Intern Med – year: 15 December 2016 ident: bb0105 article-title: Chronic obstructive pulmonary disease individualized therapy: Tailored approach to symptom management publication-title: Adv Ther – volume: 182 start-page: 598 year: 2010 end-page: 604 ident: bb0140 article-title: Chronic obstructive pulmonary disease phenotypes. The future of COPD publication-title: Am J Respir Crit Care Med – volume: 100 start-page: 115 year: 2006 end-page: 122 ident: bb0025 article-title: Global Initiative on Obstructive Lung Disease (GOLD) Classification of Lung Disease and Mortality: Findings From the Atherosclerosis Risk in Communities (ARIC) study Respiratory Medicine – volume: 145 start-page: 1321 year: 1992 end-page: 1327 ident: bb0230 article-title: A self-complete measure for chronic airflow limitation - the St George's respiratory questionnaire publication-title: Am Rev Respir Dis – volume: 48 start-page: 247 year: Jul 2012 end-page: 257 ident: bb0155 article-title: Spanish COPD guidelines (GesEPOC): pharmacological treatment of stable COPD publication-title: Arch Bronconeumol – volume: 14 start-page: 112 year: Oct 21 2013 ident: bb0055 article-title: COPD symptoms in the morning: impact, evaluation and management publication-title: Respir Res – volume: 46 start-page: 617 year: 2010 end-page: 620 ident: bb0135 article-title: Estrategias de tratamiento en la enfermedad pulmonary obstructiva crónica: una propuesta de sistematización publication-title: Arch Bronconeumol – volume: 64 start-page: 728 year: 2009 end-page: 735 ident: bb0195 article-title: The overlap syndrome of asthma and COPD: what are its features and how important is it? publication-title: Thorax – volume: 2 start-page: 75 year: 2005 end-page: 79 ident: bb0220 article-title: St. George's respiratory questionnaire: MCID publication-title: COPD – volume: 374 start-page: 733 year: 2009 end-page: 743 ident: bb0030 article-title: Chronic obstructive pulmonary disease in non-smokers publication-title: Lancet – volume: 3 start-page: 15 year: 2005 ident: bb0250 article-title: Factor structure of the Hospital Anxiety and Depression Scale (HADS) in German coronary heart disease patients publication-title: Health Qual Life Outcomes – year: 1983 ident: 10.1016/j.ejim.2017.05.021_bb0280 – volume: 132 start-page: 456 year: 2006 ident: 10.1016/j.ejim.2017.05.021_bb0235 article-title: Development and validation of an improved COPD-specific version of the St George's respiratory questionnaire publication-title: Chest doi: 10.1378/chest.06-0702 – volume: 45 start-page: 27 issue: Suppl. 5 year: 2009 ident: 10.1016/j.ejim.2017.05.021_bb0130 article-title: Tratamiento individualizado de la EPOC: una propuesta de cambio publication-title: Arch Bronconeumol doi: 10.1016/S0300-2896(09)72952-7 – volume: 150 start-page: 97 issue: 1 year: 2007 ident: 10.1016/j.ejim.2017.05.021_bb0255 article-title: Rasch analysis of the scoring scheme of the HADS depression subscale in Chinese stroke patients publication-title: Psychiatry Res doi: 10.1016/j.psychres.2006.01.015 – volume: 61 start-page: 1032 issue: 12 year: 2006 ident: 10.1016/j.ejim.2017.05.021_bb0020 article-title: Underdiagnosed chronic obstructive pulmonary disease in England: new country, same story publication-title: Thorax doi: 10.1136/thx.2006.067785 – volume: 13 start-page: 561 issue: 5 year: 2016 ident: 10.1016/j.ejim.2017.05.021_bb0065 article-title: The relationship between 24hour symptoms and COPD exacerbations and healthcare resource use: results from an observational study (ASSESS) publication-title: COPD: J Chron Obstruct Pulmon Dis doi: 10.3109/15412555.2016.1150447 – volume: 100 start-page: 115 year: 2006 ident: 10.1016/j.ejim.2017.05.021_bb0025 – volume: 64 start-page: 728 year: 2009 ident: 10.1016/j.ejim.2017.05.021_bb0195 article-title: The overlap syndrome of asthma and COPD: what are its features and how important is it? publication-title: Thorax doi: 10.1136/thx.2008.108027 – volume: 187 start-page: 347 year: 2013 ident: 10.1016/j.ejim.2017.05.021_bb0100 article-title: Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary publication-title: Am J Respir Crit Care Med doi: 10.1164/rccm.201204-0596PP – volume: 145 start-page: 1321 year: 1992 ident: 10.1016/j.ejim.2017.05.021_bb0230 article-title: A self-complete measure for chronic airflow limitation - the St George's respiratory questionnaire publication-title: Am Rev Respir Dis doi: 10.1164/ajrccm/145.6.1321 – volume: 15 start-page: 122 year: 2014 ident: 10.1016/j.ejim.2017.05.021_bb0080 article-title: Observational study to characterize 24-hour COPD symptoms and their relationship with patient-reported outcomes; results from the ASSESS study publication-title: Respir Res doi: 10.1186/s12931-014-0122-1 – volume: 37 start-page: 264 year: 2011 ident: 10.1016/j.ejim.2017.05.021_bb0035 article-title: Symptom variability in patients with severe COPD: a pan-European cross-sectional study publication-title: Eur Respir J doi: 10.1183/09031936.00051110 – volume: 374 start-page: 733 year: 2009 ident: 10.1016/j.ejim.2017.05.021_bb0030 article-title: Chronic obstructive pulmonary disease in non-smokers publication-title: Lancet doi: 10.1016/S0140-6736(09)61303-9 – volume: 182 start-page: 598 year: 2010 ident: 10.1016/j.ejim.2017.05.021_bb0140 article-title: Chronic obstructive pulmonary disease phenotypes. The future of COPD publication-title: Am J Respir Crit Care Med doi: 10.1164/rccm.200912-1843CC – year: 2017 ident: 10.1016/j.ejim.2017.05.021_bb0110 – volume: 8 start-page: 595 year: 2013 ident: 10.1016/j.ejim.2017.05.021_bb0075 article-title: Impact of night-time symptoms in COPD: a real-world study in five European countries publication-title: Int J Chron Obstruct Pulmon Dis doi: 10.2147/COPD.S48570 – volume: 54 start-page: 581 year: 1999 ident: 10.1016/j.ejim.2017.05.021_bb0205 article-title: Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease publication-title: Thorax doi: 10.1136/thx.54.7.581 – volume: 11 start-page: 3 year: 2016 ident: 10.1016/j.ejim.2017.05.021_bb0175 article-title: Diagnosis, assessment, and phenotyping of COPD: beyond FEV1 publication-title: Int J Chron Obstruct Pulmon Dis – volume: 363 start-page: 1128 year: 2010 ident: 10.1016/j.ejim.2017.05.021_bb0145 article-title: Susceptibility to exacerbation in chronic obstructive pulmonary disease publication-title: N Engl J Med doi: 10.1056/NEJMoa0909883 – volume: 20 start-page: 183 issue: 121 year: 2011 ident: 10.1016/j.ejim.2017.05.021_bb0070 article-title: Night-time symptoms: a forgotten dimension of COPD publication-title: Eur Respir Rev doi: 10.1183/09059180.00004311 – volume: 66 start-page: 430 year: 2011 ident: 10.1016/j.ejim.2017.05.021_bb0150 article-title: Identification and prospective validation of clinically relevant chronic obstructive pulmonary disease (COPD) phenotypes publication-title: Thorax doi: 10.1136/thx.2010.154484 – volume: 135 start-page: 975 issue: 4 year: 2009 ident: 10.1016/j.ejim.2017.05.021_bb0160 article-title: Cough and sputum production are associated with frequent exacerbations and hospitalizations in COPD subjects publication-title: Chest doi: 10.1378/chest.08-2062 – volume: 10 start-page: 2451 year: 2015 ident: 10.1016/j.ejim.2017.05.021_bb0170 article-title: COPD: it is time to change! publication-title: Int J COPD – volume: 48 start-page: 247 issue: 7 year: 2012 ident: 10.1016/j.ejim.2017.05.021_bb0155 article-title: Spanish COPD guidelines (GesEPOC): pharmacological treatment of stable COPD publication-title: Arch Bronconeumol doi: 10.1016/j.arbres.2012.04.001 – volume: 92 start-page: 295 year: 2016 ident: 10.1016/j.ejim.2017.05.021_bb0180 – volume: 25 start-page: 2043 year: 2009 ident: 10.1016/j.ejim.2017.05.021_bb0050 article-title: Patient insight into the impact of chronic obstructive pulmonary disease in the morning: an internet survey publication-title: Curr Med Res Opin doi: 10.1185/03007990903103006 – volume: 140 start-page: 626 year: 2011 ident: 10.1016/j.ejim.2017.05.021_bb0200 article-title: The chronic bronchtic phenotype of COPD. An analysis of the COPD gene study publication-title: Chest doi: 10.1378/chest.10-2948 – volume: 101 start-page: 453 year: 2007 ident: 10.1016/j.ejim.2017.05.021_bb0090 article-title: Patient's perception of exacerbations of COPD – the PERCEIVE study publication-title: Respir Med doi: 10.1016/j.rmed.2006.07.010 – volume: 4 start-page: 321 year: 2009 ident: 10.1016/j.ejim.2017.05.021_bb0120 article-title: Targeted treatment in COPD: a multi-system approach for a multi-system disease publication-title: Int J Chron Obstruct Pulmon Dis doi: 10.2147/COPD.S2999 – volume: 32 start-page: S457 year: 2000 ident: 10.1016/j.ejim.2017.05.021_bb0215 article-title: Comparison of three methods for measuring the time spent in physical activity publication-title: Med Sci Sports Exerc doi: 10.1097/00005768-200009001-00004 – volume: 67 start-page: 361 year: 1983 ident: 10.1016/j.ejim.2017.05.021_bb0240 article-title: The hospital anxiety and depression scale publication-title: Acta Psychiatr Scand doi: 10.1111/j.1600-0447.1983.tb09716.x – volume: 3 start-page: 15 year: 2005 ident: 10.1016/j.ejim.2017.05.021_bb0250 article-title: Factor structure of the Hospital Anxiety and Depression Scale (HADS) in German coronary heart disease patients publication-title: Health Qual Life Outcomes doi: 10.1186/1477-7525-3-15 – volume: 47 start-page: 1245 issue: 11 year: 1994 ident: 10.1016/j.ejim.2017.05.021_bb0190 article-title: Validation of a combined comorbidity index publication-title: J Clin Epidemiol doi: 10.1016/0895-4356(94)90129-5 – volume: 48 start-page: 3 year: 2012 ident: 10.1016/j.ejim.2017.05.021_bb0045 article-title: Variability of respiratory symptoms in severe COPD publication-title: Arch Bronconeumol doi: 10.1016/j.arbres.2011.07.004 – volume: 40 start-page: 373 issue: 5 year: 1987 ident: 10.1016/j.ejim.2017.05.021_bb0185 article-title: A new method of classifying prognostic comorbidity in longitudinal studies: development and validation publication-title: J Chronic Dis doi: 10.1016/0021-9681(87)90171-8 – volume: 85 start-page: 25 issue: Suppl. B year: 1991 ident: 10.1016/j.ejim.2017.05.021_bb0225 article-title: The St George's respiratory questionnaire publication-title: Respir Med doi: 10.1016/S0954-6111(06)80166-6 – volume: 20 start-page: 639 issue: 6 year: 2011 ident: 10.1016/j.ejim.2017.05.021_bb0265 article-title: The HADS and the DT for screening psychosocial distress of cancer patients in Taiwan publication-title: Psychooncology doi: 10.1002/pon.1952 – volume: 47 start-page: 271 year: 2011 ident: 10.1016/j.ejim.2017.05.021_bb0125 article-title: Corticosteroides inhalados en la EPOC por fenotipo en lugar de por gravedad. Argumentos a favor publication-title: Arch Bronconeumol doi: 10.1016/j.arbres.2011.01.016 – volume: 153 start-page: 1530 issue: 5 year: 1996 ident: 10.1016/j.ejim.2017.05.021_bb0165 article-title: Association of chronic mucus hypersecretion with FEV1 decline and chronic obstructive pulmonary disease morbidity. Copenhagen City Heart Study Group publication-title: Am J Respir Crit Care Med doi: 10.1164/ajrccm.153.5.8630597 – volume: 7 start-page: 98 year: 2009 ident: 10.1016/j.ejim.2017.05.021_bb0275 article-title: Development and psychometric assessment of the COPD and Asthma Sleep Impact Scale (CASIS) publication-title: Health Qual Life Outcomes doi: 10.1186/1477-7525-7-98 – volume: 46 start-page: 617 year: 2010 ident: 10.1016/j.ejim.2017.05.021_bb0135 article-title: Estrategias de tratamiento en la enfermedad pulmonary obstructiva crónica: una propuesta de sistematización publication-title: Arch Bronconeumol doi: 10.1016/j.arbres.2010.06.003 – year: 2016 ident: 10.1016/j.ejim.2017.05.021_bb0105 article-title: Chronic obstructive pulmonary disease individualized therapy: Tailored approach to symptom management publication-title: Adv Ther – volume: 7 start-page: 4 year: 2008 ident: 10.1016/j.ejim.2017.05.021_bb0260 article-title: Hospital Anxiety and Depression Scale (HADS): validation in a Greek general hospital sample publication-title: Ann Gen Psychiatry doi: 10.1186/1744-859X-7-4 – volume: 28 start-page: 523 year: 2006 ident: 10.1016/j.ejim.2017.05.021_bb0005 article-title: Global burden of COPD: systematic review and meta-analysis publication-title: Eur Respir J doi: 10.1183/09031936.06.00124605 – volume: 14 start-page: 112 year: 2013 ident: 10.1016/j.ejim.2017.05.021_bb0055 article-title: COPD symptoms in the morning: impact, evaluation and management publication-title: Respir Res doi: 10.1186/1465-9921-14-112 – volume: 175 start-page: 452 year: 1999 ident: 10.1016/j.ejim.2017.05.021_bb0270 article-title: Validation of the HADS in adolescents publication-title: Br J Psychiatry doi: 10.1192/bjp.175.5.452 – volume: 59 start-page: 328 issue: 4 year: 2011 ident: 10.1016/j.ejim.2017.05.021_bb0040 article-title: A cross-sectional observational study to investigate daily symptom variability, effects of symptom on morning activities and therapeutic expectations of patients and physicians in COPD-SUNRISE study publication-title: Tüberküloz ve Toraks Dergisi doi: 10.5578/tt.3268 – volume: 10 start-page: 1 year: 2013 ident: 10.1016/j.ejim.2017.05.021_bb0060 article-title: Real world COPD: association of morning symptoms with clinical and patient reported outcomes publication-title: COPD: J Chron Obstruct Pulmon Dis doi: 10.3109/15412555.2013.844784 – volume: 42 start-page: 17 year: 1997 ident: 10.1016/j.ejim.2017.05.021_bb0245 article-title: International experiences with the hospital anxiety and depression scale—a review of validation data and clinical results publication-title: J Psychosom Res doi: 10.1016/S0022-3999(96)00216-4 – volume: 4 start-page: 31 year: 2006 ident: 10.1016/j.ejim.2017.05.021_bb0095 article-title: Negative impact of chronic obstructive pulmonary disease on the health-related quality of life of patients. Results of the EPIDEPOC study publication-title: Health Qual Life Outcomes doi: 10.1186/1477-7525-4-31 – volume: 127 start-page: 1072 year: 1997 ident: 10.1016/j.ejim.2017.05.021_bb0085 article-title: Chronic obstructive pulmonary disease stage and health-related quality of life. The quality of life of chronic obstructive pulmonary disease study group publication-title: Ann Intern Med doi: 10.7326/0003-4819-127-12-199712150-00003 – volume: 2 start-page: 75 year: 2005 ident: 10.1016/j.ejim.2017.05.021_bb0220 article-title: St. George's respiratory questionnaire: MCID publication-title: COPD doi: 10.1081/COPD-200050513 – volume: 370 start-page: 741 year: 2007 ident: 10.1016/j.ejim.2017.05.021_bb0010 article-title: International variation in the prevalence of COPD (The BOLD Study): a population-based prevalence study publication-title: Lancet doi: 10.1016/S0140-6736(07)61377-4 – volume: 34 start-page: 648 year: 2009 ident: 10.1016/j.ejim.2017.05.021_bb0210 article-title: Development and first validation of the COPD Assessment Test publication-title: Eur Respir J doi: 10.1183/09031936.00102509 |
| SSID | ssj0017003 |
| Score | 2.188655 |
| Snippet | Chronic obstructive pulmonary disease (COPD) is one of the leading causes of morbidity and mortality worldwide. The symptoms of COPD are troublesome, variable,... Abstract Chronic obstructive pulmonary disease (COPD) is one of the leading causes of morbidity and mortality worldwide. The symptoms of COPD are troublesome,... |
| SourceID | proquest pubmed crossref elsevier |
| SourceType | Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 62 |
| SubjectTerms | 24-Hour symptoms Circadian Rhythm COPD Cross-Sectional Studies Disease Progression Female Health-related quality of life (HRQoL) Healthcare resources utilization Humans Internal Medicine Italy Longitudinal Studies Male Phenotype Pulmonary Disease, Chronic Obstructive - physiopathology Quality of Life Research Design Surveys and Questionnaires |
| Title | Characterization of circadian COPD symptoms by phenotype: Methodology of the STORICO observational study |
| URI | https://www.clinicalkey.com/#!/content/1-s2.0-S0953620517302194 https://www.clinicalkey.es/playcontent/1-s2.0-S0953620517302194 https://dx.doi.org/10.1016/j.ejim.2017.05.021 https://www.ncbi.nlm.nih.gov/pubmed/28576398 https://www.proquest.com/docview/1905740078 |
| Volume | 43 |
| WOSCitedRecordID | wos000414811400032&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVESC databaseName: Elsevier SD Freedom Collection Journals 2021 customDbUrl: eissn: 1879-0828 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0017003 issn: 0953-6205 databaseCode: AIEXJ dateStart: 19990501 isFulltext: true titleUrlDefault: https://www.sciencedirect.com providerName: Elsevier |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1bb9MwFLa6DSFeENdRLpOReKtSJU6cC29TGTDE2okV6JsVO45otSVV000bf4E_zXHseKHdxkXiJYqsOE58Ph9_PvY5B6FXKcmy0M2lk-bKdMNzGHM0EU4YZ0RySrmsM899-RgNh_Fkkhx2Oj8aX5iz46go4vPzZP5fRQ1lIGzlOvsX4rYvhQK4B6HDFcQO1z8S_MCGYP5u6aCYLoQOQjAYHb7pVRcn82V5Uinuqc54lcoQq2wDB3U-aR2WyRweOBqPPu0PRr2SW_tt7WLSRKW9yqrfCkVR369u4A_SQkXkrXnru_7XvrUJKJ_Omk7bItA9yt-81IbX4WU5YKzQnt39tuUCZsPmaJYxp6251Bi7pO-ExKVtFR34LR1rtLeerXVOnrV5QJskZn05m6pwA54Oz6p9sVfiax-pFlWDHig70N_BBtoiEU1Ay2_t7u9NPthNqcitE23bLzQ-WPq44GpL1_Gc69YxNZ8Z30N3zUIE72oA3UcdWTxAtw-MpB6ib6s4wmWOLY6wwhFucIT5BbY4eo1bKFKVAEXYoAj_giJco-gR-vx2bzx475i0HI4IQrJ0Mi_1vMznIs9dEcRhmEaZ4Hnk5TEsTz1JgizJuYhJJDlxZUiA86ZC7QeTJOTA_x-jTUCZfIJw6HuZl6RxSGUe0ITAOymnxPVp5oo4F13kNZ3IhIlZr1KnHLPmcOKMqY5nquOZSxl0fBf1bJ25jthy49N-IxvW-CLD7MkASDfWiq6qJSszxirmsYowl62Bq4uorWk4ruauv23xZQMcBhOA2tVLC1meQksJLLkCRfW7aFsjyv43iSnwhyR--k9_-QzduRy2z9HmcnEqX6Bb4mw5rRY7aCOaxDtmjPwEfGrgTQ |
| linkProvider | Elsevier |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Characterization+of+circadian+COPD+symptoms+by+phenotype%3A+Methodology+of+the+STORICO+observational+study&rft.jtitle=European+journal+of+internal+medicine&rft.au=Canonica%2C+G.W.&rft.au=Blasi%2C+F.&rft.au=Scichilone%2C+N.&rft.au=Simoni%2C+L.&rft.date=2017-09-01&rft.pub=Elsevier+B.V&rft.issn=0953-6205&rft.volume=43&rft.spage=62&rft.epage=68&rft_id=info:doi/10.1016%2Fj.ejim.2017.05.021&rft.externalDocID=S0953620517302194 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0953-6205&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0953-6205&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0953-6205&client=summon |